Related Experiment Videos
Chondrosarcoma of the hyoid
S Hasan1, V Kannan, A M Shenoy
1Department of Radiation Oncology, Kidwai Memorial Institute of Oncology, Bangalore, India.
The Journal of Laryngology and Otology
|March 1, 1992
Summary
Surgical resection and radiotherapy effectively treated two cases of hyoid bone chondrosarcoma. Patients remain disease-free at 26 and 15 months post-treatment, indicating successful management of this rare bone cancer.
Area of Science:
- Oncology
- Head and Neck Surgery
- Orthopedic Oncology
Background:
- Chondrosarcoma is a rare malignant tumor arising from cartilage-producing cells.
- Hyoid bone chondrosarcoma is exceptionally rare, posing diagnostic and therapeutic challenges.
- Optimal management strategies for hyoid bone chondrosarcoma require further elucidation.
Observation:
- This report details two unique cases of chondrosarcoma originating in the hyoid bone.
- Both patients presented with symptoms necessitating surgical intervention.
- The tumors were characterized histopathologically as chondrosarcoma.
Findings:
- Surgical resection was performed for both hyoid bone chondrosarcoma cases.
- Postoperative radiotherapy was administered as an adjuvant treatment modality.
- Both patients achieved disease-free status at 26 months and 15 months follow-up, respectively.
Implications:
- This case series suggests that a combined approach of surgical resection and radiotherapy can be effective for hyoid bone chondrosarcoma.
- The findings support the consideration of this multimodal treatment strategy for similar rare presentations.
- Long-term follow-up is crucial for assessing outcomes in patients with hyoid bone chondrosarcoma.